Back
AngioDynamics 10K Form
Sell
46
ANGO
AngioDynamics
Last Price:
6.74
Seasonality Move:
11.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-09 | 10Q | ANGO/AngioDynamics Quarterly |
2024-01-08 | 10Q | ANGO/AngioDynamics Quarterly |
2023-10-05 | 10Q | ANGO/AngioDynamics Quarterly |
2023-08-03 | 10K | ANGO/AngioDynamics Annual |
2023-03-31 | 10Q | ANGO/AngioDynamics Quarterly |
2023-01-06 | 10Q | ANGO/AngioDynamics Quarterly |
Receive ANGO News And Ratings
See the #1 stock for the next 7 days that we like better than ANGO
ANGO Financial Statistics
Sales & Book Value
Annual Sales: | $303.91M |
---|---|
Cash Flow: | $-19.35M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.79 |
Price / Book: | 1.39 |
Profitability
EPS (TTM): | -6.03000 |
---|---|
Net Income (TTM): | $-243.03M |
Gross Margin: | $154.7M |
Return on Equity: | -83.81% |
Return on Assets: | -62.97% |
AngioDynamics Earnings Forecast
Key AngioDynamics Financial Ratios
- The Gross Profit Margin over the past 24 years for ANGO is 50.90%.
- The Selling, General & Administrative Expenses for ANGO have been equal to 47.38% of Gross Profit Margin.
- The Research & Development expenses have been 10.37% of Revenue.
- The Interest Expense is -5.15% of Operating Income.
- The Net Earning history of ANGO is -60.66% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 14 years.
AngioDynamics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | ANGO |
CUSIP: | 03475V |
Website: | angiodynamics.com |
Debt
Debt-to-Equity Ratio: | 0.02 |
---|---|
Current Ratio: | 2.25 |
Quick Ratio: | 1.23 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ANGO Technical Analysis vs Fundamental Analysis
Sell
46
AngioDynamics (ANGO)
is a Sell
Is AngioDynamics a Buy or a Sell?
-
AngioDynamics stock is rated a Sell
The current AngioDynamics [ANGO] share price is $6.74. The Score for ANGO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.